qcom eli lilly - Search News

Weight Loss Drug Demand Drives Eli Lilly Sales

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast.

CNBC on MSN · 1d

Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Reuters on MSN · 19h

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs. Lilly said o

Business Insider · 1d

LLY Earnings: Weight Loss Drug Demand Drives Eli Lilly Sales as Investors Eye Next-Gen Treatments

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in

11h

Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Hosted on MSN14d

Is QUALCOMM Incorporated (QCOM) the Best Stock to Invest In For Steady Dividends?

Madison Investments highlighted QCOM in its Q3 2024 investor letter. Here is what the firm has to say: “Alphabet Inc., Eli Lilly and Company, QUALCOMM Incorporated (NASDAQ:QCOM), Microsoft ...

Insider Monkey25d

Is QUALCOMM Incorporated (QCOM) the Most Reliable Dividend Stock to Buy According to Hedge Funds?

Bill McEwen20h

Stock Market Today: Wall Street Drifts as Gains for Fashion Brands Help Offset Qualcomm's Slide

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Yahoo Finance24d

Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results